Influence of Different Tamponade Eyes on IOL-capsular Complex
NCT ID: NCT05296486
Last Updated: 2022-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2022-04-01
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The IOL-capsular complex is formed after cataract surgery and intraocular lens (IOL) implantation. Early postoperative mechanical wrapping of the anterior and posterior capsules plays a significant role in preventing IOL decentration and tilt, as well as formation of the IOL-capsular complex which reduces the incidence of posterior cataract opacity.
Although up to 2-3 degree tilt and a 0.2-0.3 mm decentration are common and clinically unnoticed, larger extent of tilt and decentration has a negative impact on the optical performance. IOL decentration ≥ 0.4 mm or/and IOL tilt ≥7degree were considered clinically significant because of poor post-surgery visual quality.
Currently, there is no literature guidance to compare the results of phacovitrectomy combined various types of intravitreal tamponade materials in patients using CASIA2. The novel anterior segment optical coherence tomography (AS-OCT) device, CASIA2 can evaluate the IOL capsule bending and the lens position after cataract surgery. Also, CASIA2 can be used to documented the dynamic changes of IOL-capsular complex after surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes
NCT03142269
Influence of Capsular Tension Ring on IOL-capsular Complex After Cataract Surgery in Patients With High Myopia: a Clinical Observation Based on SS-OCT
NCT05095194
Anterior Segment Changes After Pars Plana Vitrectomy With SO Using AS-OCT
NCT06524661
Intraoperative and Postoperative Outcomes of Three Ophthalmic Viscosurgical Devices During Phacoemulsification
NCT01664689
Comparison of Manual Super Small Incision Cataract Surgery and Phacoemulsification
NCT01146964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The IOL-capsular complex is formed after cataract surgery and intraocular lens (IOL) implantation. Early postoperative mechanical wrapping of the anterior and posterior capsules plays a significant role in preventing IOL decentration and tilt, as well as formation of the IOL-capsular complex which reduces the incidence of posterior cataract opacity.
Although up to 2-3 degree tilt and a 0.2-0.3 mm decentration are common and clinically unnoticed, larger extent of tilt and decentration has a negative impact on the optical performance. IOL decentration ≥ 0.4 mm or/and IOL tilt ≥7degree were considered clinically significant because of poor post-surgery visual quality.
Currently, there is no literature guidance to compare the results of phacovitrectomy combined various types of intravitreal tamponade materials in patients using CASIA2. The novel anterior segment optical coherence tomography (AS-OCT) device, CASIA2 can evaluate the IOL capsule bending and the lens position after cataract surgery. Also, CASIA2 can be used to documented the dynamic changes of IOL-capsular complex after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
phacovitrectomy surgery with silicone oil tamponade
patients who had phacovitrectomy surgery with silicone oil tamponade.The patients diagnosed cataract The patients' ages are over 50.
phacovitrectomy surgery with silicone oil tamponade
Patients in this study will receive phacovitrectomy surgery with silicone oil tamponade.
phacovitrectomy surgery with gas tamponade
patients who had phacovitrectomy surgery with gas tamponade.The patients diagnosed cataract The patients' ages are over 50.
phacovitrectomy surgery with gas tamponade
Patients in this study will receive phacovitrectomy surgery with gas tamponade
phacovitrectomy surgery with balanced saline solution tamponade
patients who had phacovitrectomy surgery with balanced saline solution tamponade.The patients diagnosed cataract The patients' ages are over 50.
phacovitrectomy surgery with balanced saline solution tamponade
Patients in this study will receive phacovitrectomy surgery with balanced saline solution tamponade
phacoemulsifacation surgery without vitrectomy
patients who had phacoemulsifacation surgery without vitrectomy.The patients diagnosed cataract The patients' ages are over 50.
phacoemulsifacation surgery without vitrectomy
Patients in this study will receive phacoemulsifacation surgery without vitrectomy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phacovitrectomy surgery with silicone oil tamponade
Patients in this study will receive phacovitrectomy surgery with silicone oil tamponade.
phacovitrectomy surgery with gas tamponade
Patients in this study will receive phacovitrectomy surgery with gas tamponade
phacovitrectomy surgery with balanced saline solution tamponade
Patients in this study will receive phacovitrectomy surgery with balanced saline solution tamponade
phacoemulsifacation surgery without vitrectomy
Patients in this study will receive phacoemulsifacation surgery without vitrectomy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients' age over 50 years old
* The patients plan to receive cataract surgery with or without vitrectomy in Eye hospital of Wenzhou Medical University
* The dilated pupils are over 7mm
* Patients are willing and able to complete the follow-ups.
Exclusion Criteria
* Patients have severe complications in the surgery and after surgery
* Patients have other severe diseases of eyes
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yune Zhao
Vice president of Eye Hospital of Wenzhou Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yune Zhao
Role: STUDY_DIRECTOR
Ophthalmology and Optometry Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Yune Zhao, MD
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IOL with different tamponade
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.